| Předmět: |
|
| Zdroj: |
Pharma Business Week; 4/30/2024, p1177-1177, 1p |
| Abstrakt: |
Neurvati Neurosciences, a clinical-stage biotechnology company focused on neurological and psychiatric disorders, has announced the appointment of Dr. Deborah Dunsire as a new member and chair of the company's board of directors. Dr. Dunsire is a respected industry veteran with a successful track record in leading neuroscience companies. She brings valuable insights and global reach to Neurvati as they plan for important milestones in their clinical development programs and business strategy. Dr. Dunsire expressed excitement about joining Neurvati and contributing to their efforts to make a meaningful difference for people with neurological and psychiatric diseases. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
